A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT07635238
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Prostate Adenocarcinoma
- Prostate Cancer
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MR-guided Stereotactic Body Radiation Therapy — RADIATIONMR-guided 2 fraction Stereotactic Body Radiation Therapy
Study Details
The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.
Key Dates
- Start date
- May 28, 2026
- Status verified
- May 2026
- Primary completion
- May 28, 2030
- Completion
- May 28, 2030
Study Design
- Enrollment
- 54 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Group 1: Uniform dose SBRT
- Experimental: Group 2: De-escalated dose SBRT
Primary Outcome Measure
Number of participants with acute GU toxicities [ Time Frame: 12 weeks from the start of radiation therapy ]
Central Contacts
- Victoria Brennan, MBBCH BAO212-639-8904
- Zachary Moore, MD, PhD212-639-5803
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | |
| Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | |
| Memorial Sloan Kettering at Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | |
| Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) | Commack | New York | 11725 | |
| Memorial Sloan Kettering at Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Victoria Brennan, MBBCH BAO 212-639-8904 |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering at Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering at Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering at Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska